Thrombin-activated interleukin-1α drives atherogenesis, but also promotes vascular smooth muscle cell proliferation

Laura C Burzynski1, Alejandra Morales-Maldonado1, Amanda Rodgers1

  • 1Section of CardioRespiratory Medicine, The Heart and Lung Research Institute, The University of Cambridge, Papworth Road, Cambridge Biomedical Campus, Cambridge CB2 0BB, UK.

PubMed

Insights

Ongoing coagulation contributes to atherosclerosis through thrombin activating interleukin-1 alpha (IL-1α). Targeting IL-1α or thrombin may offer therapeutic benefits for cardiovascular disease.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Hematology

Background:

  • Atherosclerosis involves complex interactions between the immune and coagulation systems.
  • The link between coagulation and immunity in atherogenesis, particularly via interleukin-1 alpha (IL-1α) activation by thrombin, is not fully understood.

Purpose of the Study:

  • To investigate the role of thrombin-mediated IL-1α activation in atherosclerosis development.
  • To characterize the impact of inhibiting this pathway on atherosclerotic plaque formation and stability.

Main Methods:

  • Generated a novel knock-in mouse model (IL-1α thrombin mutant, IL-1αTM) unable to activate IL-1α via thrombin.
  • Utilized Apoe-/- mice to study atherosclerotic plaque formation and composition.
  • Employed bone marrow chimera experiments to determine the cellular origin of thrombin-activated IL-1α.

Main Results:

  • IL-1αTM/Apoe-/- mice exhibited reduced atherosclerotic plaque formation and T-cell infiltration compared to controls.
  • However, plaques in IL-1αTM/Apoe-/- mice showed decreased vascular smooth muscle cells, collagen, and fibrous caps, indicating increased instability.
  • Thrombin inhibitors' anti-atherogenic effects were diminished in IL-1αTM/Apoe-/- mice, suggesting mediation through IL-1α.
  • Thrombin-activated IL-1α originates from both vessel wall and myeloid cells.

Conclusions:

  • The atherogenic effects of coagulation are partly mediated by thrombin cleavage of IL-1α.
  • This highlights the crucial interplay between coagulation and immunity in atherosclerosis.
  • Targeting IL-1α and/or thrombin presents potential therapeutic strategies.
  • IL-1α may also influence atherosclerotic plaque stabilization.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
767
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K